Davis AR - Search Results

1

Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine.

Tacket CO, Losonsky G, Lubeck MD, Davis AR, Mizutani S, Horwith G, Hung P, Edelman R, Levine MM. Tacket CO, et al. Among authors: davis ar. Vaccine. 1992;10(10):673-6. doi: 10.1016/0264-410x(92)90088-2. Vaccine. 1992. PMID: 1523878 Clinical Trial.

2

Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs.

Chengalvala M, Lubeck MD, Davis AR, Mizutani S, Molnar-Kimber K, Morin J, Hung PP. Chengalvala M, et al. Among authors: davis ar. Vaccine. 1991 Jul;9(7):485-90. doi: 10.1016/0264-410x(91)90033-3. Vaccine. 1991. PMID: 1832806

3

Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret model.

Hsu KH, Lubeck MD, Bhat BM, Bhat RA, Kostek B, Selling BH, Mizutani S, Davis AR, Hung PP. Hsu KH, et al. Among authors: davis ar. Vaccine. 1994 May;12(7):607-12. doi: 10.1016/0264-410x(94)90264-x. Vaccine. 1994. PMID: 8085377

4

Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vector.

Ye WW, Mason BB, Chengalvala M, Cheng SM, Zandle G, Lubeck MD, Lee SG, Mizutani S, Davis AR, Hung PP. Ye WW, et al. Among authors: davis ar. Arch Virol. 1991;118(1-2):11-27. doi: 10.1007/BF01311300. Arch Virol. 1991. PMID: 1828660

5

Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus.

Lubeck MD, Davis AR, Chengalvala M, Natuk RJ, Morin JE, Molnar-Kimber K, Mason BB, Bhat BM, Mizutani S, Hung PP, et al. Lubeck MD, et al. Among authors: davis ar. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6763-7. doi: 10.1073/pnas.86.17.6763. Proc Natl Acad Sci U S A. 1989. PMID: 2570422 Free PMC article.

6

Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters.

Morin JE, Lubeck MD, Barton JE, Conley AJ, Davis AR, Hung PP. Morin JE, et al. Among authors: davis ar. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4626-30. doi: 10.1073/pnas.84.13.4626. Proc Natl Acad Sci U S A. 1987. PMID: 2955413 Free PMC article.

7

Immunogenicity of recombinant influenza virus haemagglutinin carrying peptides from the envelope protein of human immunodeficiency virus type 1.

Kalyan NK, Lee SG, Wilhelm J, Pisano MR, Hum WT, Hsiao CL, Davis AR, Eichberg JW, Robert-Guroff M, Hung PP. Kalyan NK, et al. Among authors: davis ar. Vaccine. 1994 Jun;12(8):753-60. doi: 10.1016/0264-410x(94)90228-3. Vaccine. 1994. PMID: 7522383

8

Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus.

Hsu KH, Crowe JE Jr, Lubeck MD, Davis AR, Hung PP, Chanock RM, Murphy BR. Hsu KH, et al. Among authors: davis ar. Vaccine. 1995 Apr;13(5):509-15. doi: 10.1016/0264-410x(94)00002-5. Vaccine. 1995. PMID: 7543716

9

Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs.

Chengalvala MV, Bhat BM, Bhat R, Lubeck MD, Mizutani S, Davis AR, Hung PP. Chengalvala MV, et al. Among authors: davis ar. J Gen Virol. 1994 Jan;75 ( Pt 1):125-31. doi: 10.1099/0022-1317-75-1-125. J Gen Virol. 1994. PMID: 8113721

10

Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee.

Hsu KH, Lubeck MD, Davis AR, Bhat RA, Selling BH, Bhat BM, Mizutani S, Murphy BR, Collins PL, Chanock RM, et al. Hsu KH, et al. Among authors: davis ar. J Infect Dis. 1992 Oct;166(4):769-75. doi: 10.1093/infdis/166.4.769. J Infect Dis. 1992. PMID: 1527411

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters